Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CNTA

Centessa Pharmaceuticals (CNTA)

Centessa Pharmaceuticals PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CNTA
DateTimeSourceHeadlineSymbolCompany
02/04/20228:31AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
12/14/20217:30AMGlobeNewswire Inc.Centessa Pharmaceuticals Initiates Global Phase 3 ACTION Study of Lixivaptan in Autosomal Dominant Polycystic Kidney Disease, Reports Initial Positive Safety Data from ALERT Study, and Announces Notice of Allowance for Key Lixivaptan U.S. Patent ApplicatioNASDAQ:CNTACentessa Pharmaceuticals PLC
12/13/20214:15PMGlobeNewswire Inc.Centessa Pharmaceuticals Announces Addition to NASDAQ Biotechnology IndexNASDAQ:CNTACentessa Pharmaceuticals PLC
12/06/20215:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
12/02/20215:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
11/30/20215:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
11/30/20215:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
11/15/20217:14AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNTACentessa Pharmaceuticals PLC
11/15/20217:00AMGlobeNewswire Inc.Centessa Pharmaceuticals Announces Third Quarter 2021 Financial Results and Business UpdatesNASDAQ:CNTACentessa Pharmaceuticals PLC
11/10/20214:45PMGlobeNewswire Inc.Centessa Pharmaceuticals to Present at Upcoming Conferences in 2021NASDAQ:CNTACentessa Pharmaceuticals PLC
11/02/20217:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTACentessa Pharmaceuticals PLC
11/01/20217:30AMGlobeNewswire Inc.Centessa Pharmaceuticals Demonstrates Proof-of-Mechanism from First Three PiMZ Subjects Dosed in Part B of Phase 1 Study Evaluating ZF874NASDAQ:CNTACentessa Pharmaceuticals PLC
10/18/20218:00AMBusiness WireCentessa Pharmaceuticals Subsidiary, Orexia Therapeutics, and Schrödinger Announce Collaboration to Discover Novel Orexin Receptor AgonistsNASDAQ:CNTACentessa Pharmaceuticals PLC
10/18/20218:00AMGlobeNewswire Inc.Centessa Pharmaceuticals Subsidiary, Orexia Therapeutics, and Schrödinger Announce Collaboration to Discover Novel Orexin Receptor AgonistsNASDAQ:CNTACentessa Pharmaceuticals PLC
10/08/20216:00PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CNTACentessa Pharmaceuticals PLC
10/05/20218:00AMGlobeNewswire Inc.Centessa Pharmaceuticals Appoints David Grainger, PhD, a Leading Biotech Entrepreneur, as Chief Innovation OfficerNASDAQ:CNTACentessa Pharmaceuticals PLC
10/04/20218:00AMGlobeNewswire Inc.Centessa Pharmaceuticals Announces $300 Million Financing Agreement with Oberland CapitalNASDAQ:CNTACentessa Pharmaceuticals PLC
09/09/20217:35AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNTACentessa Pharmaceuticals PLC
09/09/20217:30AMGlobeNewswire Inc.Centessa Pharmaceuticals Announces Positive Topline Data from Proof-of-Concept Study of SerpinPC in Severe Hemophilia A and B Patients Not on ProphylaxisNASDAQ:CNTACentessa Pharmaceuticals PLC
09/01/20214:15PMGlobeNewswire Inc.Centessa Pharmaceuticals to Present at the Morgan Stanley Virtual 19th Annual Global Healthcare ConferenceNASDAQ:CNTACentessa Pharmaceuticals PLC
08/16/20217:12AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CNTACentessa Pharmaceuticals PLC
08/16/20217:00AMGlobeNewswire Inc.Centessa Pharmaceuticals Announces Second Quarter 2021 Financial Results and Business UpdatesNASDAQ:CNTACentessa Pharmaceuticals PLC
06/07/20214:15PMGlobeNewswire Inc.Centessa Pharmaceuticals to Present at the Goldman Sachs 42nd Annual Global Healthcare ConferenceNASDAQ:CNTACentessa Pharmaceuticals PLC
06/07/20214:00AMBusiness WireCiti Appointed as Depositary Bank for Centessa Pharmaceuticals plc’s ADR ProgrammeNASDAQ:CNTACentessa Pharmaceuticals PLC
06/04/20214:15PMGlobeNewswire Inc.Centessa Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs...NASDAQ:CNTACentessa Pharmaceuticals PLC
 Showing the most relevant articles for your search:NASDAQ:CNTA